For instance, fresolimumab, a human anti-TGF-β monoclonal antibody, has demonstrated efficacy against melanoma and renal cell activity in clinical trials, while pirfenidone can directly inhibit TGF-β production and alleviate pulmonary fibrosis [53, 54]. The gene discussed is TGFB1; the disease is melanoma.